Position in ABSI
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$303,924
New position
Shares Held
26,223
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#122
of 195 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthfront Advisers LLC holds $35,327,037 across 19 Biotechnology names. ABSI ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,608 | $20,667,941 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,006 | $4,368,521 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,554 | $2,876,040 | |
| 4 | INSM |
INSMED Inc
|
17,511 | $1,867,022 | |
| 5 | INCY |
Incyte Corp
|
9,753 | $1,105,600 | |
| 6 | MRNA |
Moderna, Inc.
|
15,621 | $1,093,938 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
39,822 | $587,772 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
8,602 | $469,153 |
All Filings in ABSI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,924 | 26,223 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||